California Biopharma Shows Promising Phase 1 Data
Research Report
Drug Trial Shows Positive Interim Results for ALS Treatment
FDA Decision on Drug for Bone Marrow Due Early 2025
Research Report
Is This California Biopharma Co. In the Right Place at the Right Time?
Research Report
Regenerative Medicine Co. Adds Saudi Arabia Diabetes Initiative
Approval Sought in Japan for New Drug to Lower Cholesterol
Research Report
AI Accelerates Breakthroughs in Cancer Drug Discovery
Intratubal Insemination Device Shown Effective, Safe
Research Report
Pregnancy rates with this "only new innovation for infertility in decades" were "impressive" in a pivotal study in women with male factor infertility, noted an H.C. Wainwright & Co. report. Developer of Medical Instruments Attracts Research Coverage
Research Report
Both of this Buy-rated company's two business divisions are contributing to topline growth, noted a Leede Financial Inc. report. Two Firms Aim To Create Functional Cure for Type 1 Diabetes
Each company is pursuing its own treatment approach to achieve insulin independence, consisting of islet cells (donor or stem cell derived), delivered into the portal vein or housed in a Cell Pouch bio-hybrid organ that is implanted in the body. Learn more about their respective programs.Biotech Initiates Phase III Trial for Heart Disease Drug
Clinical-stage life sciences company Cardiol Therapeutics (CRDL:TSX; CRDL:NASDAQ) is setting up a phase III trial for its pericarditis drug, CardioRx, after pilot study sees success. Read why analysts like this biotech stock.Breakthrough Therapy Shows Promising Long-Term Results for Depression
Cybin Inc. (CYBN:NYSE American; CYBN:NEO) has announced positive results from its 12-month Phase 2 study of CYB003, a proprietary deuterated psilocin program designed for the adjunctive treatment of major depressive disorder (MDD). Find out about the FDA's designation of this treatment and why the Chief Medical Officer sees this news as "highly encouraging."Analyst Says Biotech's Data Supports Advancement Into Phase III
Research Report
Cardiol Therapeutics (CRDL:TSX; CRDL:NASDAQ) recently released updated Phase II data from the MAvERIC trial testing CardiolRx in recurrent pericarditis, according to a Leede Financial Inc. research note. Transformative Moves in Harm Reduction Expanding Market Reach with New Partnerships and Acquisitions
Safe Supply Streaming Co. Ltd (SPLY:CSE; SSPLF:OTCQB; QM4:FSE) recently announced significant developments within its portfolio company, Safety Strips, and a key acquisition. Learn more about how these strategic developments aim to enhance harm reduction efforts and expand market reach.Opportunity Arises for Co. With Cell Pouch
Research Report
This medical device owner could team up with a biotech firm that just prioritized its diabetes program, noted a Leede Financial Inc. report. 
Streetwise Key Charts
